- Filed
- May 13, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 5, 2025 | 4.64M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $109.97M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $114.69M |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $5.88M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $1.26M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $13.73M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $26.11M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $39.94M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $34.99M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $200.61M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $202.38M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $88.69M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $95.21M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $410.56M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $426.1M |
| Revenue | Q1 2025 · Mar 31, 2025 | $40.53M |
| Revenue | Q1 2025 · Mar 31, 2024 | $54.17M |
| Shares Diluted restated | Q1 2025 · Mar 31, 2024 | 4.58M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $1.44M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$2.3M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $278.03M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $290.61M |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | −$2.75 |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | −$2.75 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $19.62M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$12.61M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$8.7M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $10.93M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $43.25M |